15 September 2025
CVS Group plc
("CVS" or the "Company")
PDMR Shareholding Correction
CVS, the UK's listed veterinary group and a leading provider of veterinary services, issues a correction to the announcement dated 25 July 2024 regarding the shares held by Paul Higgs, Director and Chief Veterinary Officer of the Company.
The Company confirms that Paul Higgs' holding in the Company is 3,696 ordinary shares of 0.2p each ("Ordinary Shares") not 6,364 as stated in the above announcement. This includes all persons closely associated.
The holding of 3,696 Ordinary Shares represents 0.005% per cent of the total voting rights of the Company.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser
Camarco (Financial PR)
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.